Top Markets
#1 Black Phoenix Black Phoenix +21,537.33%
#2 Nesa Nesa +772.80%
#3 Cortex Cortex +68.63%
#4 Kinesis Silver Kinesis Silver +55.36%
#5 QuantixAI QuantixAI +23.76%
#6 EXOD EXOD +22.78%
#7 Derive Derive +19.90%
#8 Cash Cat Cash Cat +16.73%
#9 Pons Pons +16.53%
#10 BNB Attestation Service BNB Attestation Service +16.09%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Rank in Stocks #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Share Price
$4.62
Last synced: 2023-03-23
Market Cap
$171.76M
Change (1 day)
-37.16%
Change (1 year)
0.00%
Country
KR
Trade Cellivery Therapeutics, Inc. (268600)

Category

Healthcare
Earnings for Cellivery Therapeutics, Inc. (268600)
Earnings in 2026 TTM: 0
According to Cellivery Therapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cellivery Therapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH